In addition, we assessed the expression of cofilin 2 in Aβ25–35 intracerebroventricular-injected rat AD model, and found that cofilin 2 was obviously increased by 61% in the hippocampus and by 88% in serum compared to the control rats (Figures 1C,D). This evidence concerns the gene CFL2 and Alzheimer disease.